Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trypanosoma cruzi | 6-phosphofructo-2-kinase 1 | 0.3187 | 0.9706 | 0.9706 |
Loa Loa (eye worm) | hypothetical protein | 0.3242 | 1 | 1 |
Onchocerca volvulus | 0.3242 | 1 | 0.5 | |
Leishmania major | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase, putative | 0.3242 | 1 | 1 |
Entamoeba histolytica | phosphoglycerate mutase family protein, putative | 0.1913 | 0.2852 | 0.5 |
Trypanosoma brucei | 6-phosphofructo-2-kinase 2 | 0.3187 | 0.9706 | 0.9706 |
Giardia lamblia | Hypothetical protein | 0.1913 | 0.2852 | 0.5 |
Brugia malayi | Raf kinase | 0.2579 | 0.6435 | 0.5 |
Schistosoma mansoni | 6-phosphofructokinase | 0.3242 | 1 | 1 |
Trypanosoma cruzi | 6-phosphofructo-2-kinase 1 | 0.3187 | 0.9706 | 0.9706 |
Loa Loa (eye worm) | raf kinase | 0.266 | 0.6866 | 0.6627 |
Trypanosoma cruzi | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase, putative | 0.3242 | 1 | 1 |
Mycobacterium ulcerans | hypothetical protein | 0.1913 | 0.2852 | 0.5 |
Giardia lamblia | Hypothetical protein | 0.1913 | 0.2852 | 0.5 |
Trypanosoma cruzi | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase, putative | 0.3242 | 1 | 1 |
Mycobacterium ulcerans | fructose-2,6-bisphosphatase GpmB | 0.1913 | 0.2852 | 0.5 |
Leishmania major | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase, putative | 0.3187 | 0.9706 | 0.9706 |
Trypanosoma brucei | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase, putative | 0.3242 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.3187 | 0.9706 | 0.9683 |
Loa Loa (eye worm) | hypothetical protein | 0.1859 | 0.2557 | 0.1988 |
Echinococcus multilocularis | 6 phosphofructo 2 kinase:fructose 2 | 0.3242 | 1 | 1 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.